Software-based Modification of Hand Tremors in XR
Launched by NEUROSTORM, INC · Dec 18, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The following trial evaluates the effect of Tremor Stabilization Algorithms on involuntary hand tremors suffered by Parkinson's patients. These algorithms will be implemented in Virtual Reality (VR). Approximately 300 study subjects are to be randomized to experimental (VR plus algorithms, i.e., intervention) and active comparator (VR only, i.e., control) study arms. Study subjects will perform a postural tremor test (PTT) to elicit postural parkinsonian tremors. Our primary outcome is whether the intervention modifies tremor severity. Secondary outcomes include determining whether tremor s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Candidates eligible for our study will be 35 - 85 years, diagnosed with Parkinson's disease, with no falls within 6 months prior to the study, are able to walk for 5 minutes unassisted, have adequate hearing and vision capabilities, can comply with study requirements, have the ability to fill online questionnaires, and provide written informed consent to participate in the study.
- Exclusion Criteria:
- • Candidates that are ineligible for our study have visual-perceptual deficits that limit capacity to be in VR, have clinical diagnosis of dementia or other severe cognitive impairment as determined by a Mini-Mental State Examination score (MMSE) of less than 24, or have a history of stroke, traumatic brain injury or other neurological disorders
About Neurostorm, Inc
Neurostorm, Inc. is a pioneering biotechnology company dedicated to advancing innovative therapeutic solutions for neurological disorders. With a strong focus on research and development, Neurostorm leverages cutting-edge science and technology to create targeted treatments that address unmet medical needs in the field of neurology. Committed to improving patient outcomes, the company collaborates with leading academic institutions and industry partners to drive clinical trials that foster the development of safe and effective interventions. Through its rigorous scientific approach and dedication to excellence, Neurostorm aims to transform the landscape of neurological care and enhance the quality of life for individuals affected by these challenging conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials